An Open-label, Multi-center, Crossover Study to Compare the Effect of Once-daily Ropinirole PR and Twice-daily Ropinirole PR in Patients With Parkinson Disease
Phase of Trial: Phase IV
Latest Information Update: 06 Sep 2013
At a glance
- Drugs Ropinirole (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 06 Sep 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 27 Jul 2010 Planned end date changed from 1 Aug 2010 to 1 Feb 2011 as reported by ClinicalTrials.gov.